Evidence Repository
The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!
  • See Evidence submitted by expert panel for details.

Variant: NM_000038.6(APC):c.5465T>A (p.Val1822Asp)

CA010422

21030 (ClinVar)

Gene: APC
Condition: familial adenomatous polyposis 1
Inheritance Mode: Autosomal dominant inheritance
Link to MONDO
UUID: 382336bf-1845-4ef0-9f6d-e061437c0adb
Approved on: 2023-02-26
Published on: 2023-03-14

HGVS expressions

NM_000038.6:c.5465T>A
NM_000038.6(APC):c.5465T>A (p.Val1822Asp)
NC_000005.10:g.112841059T>A
CM000667.2:g.112841059T>A
NC_000005.9:g.112176756T>A
CM000667.1:g.112176756T>A
NC_000005.8:g.112204655T>A
NG_008481.4:g.153539T>A
ENST00000257430.9:c.5465T>A
ENST00000257430.8:c.5465T>A
ENST00000508376.6:c.5465T>A
ENST00000508624.5:c.*4787T>A
ENST00000520401.1:n.230+12087T>A
NM_000038.5:c.5465T>A
NM_001127510.2:c.5465T>A
NM_001127511.2:c.5411T>A
NM_001354895.1:c.5465T>A
NM_001354896.1:c.5519T>A
NM_001354897.1:c.5495T>A
NM_001354898.1:c.5390T>A
NM_001354899.1:c.5381T>A
NM_001354900.1:c.5342T>A
NM_001354901.1:c.5288T>A
NM_001354902.1:c.5192T>A
NM_001354903.1:c.5162T>A
NM_001354904.1:c.5087T>A
NM_001354905.1:c.4985T>A
NM_001354906.1:c.4616T>A
NM_001127510.3:c.5465T>A
NM_001127511.3:c.5411T>A
NM_001354895.2:c.5465T>A
NM_001354896.2:c.5519T>A
NM_001354897.2:c.5495T>A
NM_001354898.2:c.5390T>A
NM_001354899.2:c.5381T>A
NM_001354900.2:c.5342T>A
NM_001354901.2:c.5288T>A
NM_001354902.2:c.5192T>A
NM_001354903.2:c.5162T>A
NM_001354904.2:c.5087T>A
NM_001354905.2:c.4985T>A
NM_001354906.2:c.4616T>A
More

Benign

Met criteria codes 2
BA1 BP1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP
The c.5465T>A variant in APC is a missense variant predicted to cause the substitution of Valine by Asparagine at amino acid position 1822 (p.Val1822Asp). APC is defined by the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel (HCCP VCEP) as a gene for which primarily truncating variants are known to cause disease (BP1). The highest population minor allele frequency in gnomAD v2.1.1 is 0.9598 (23897/24898 alleles) in the African/African American population, which is higher than the ClinGen APC VCEP threshold (>0.1%) for BA1, and therefore meets this criterion (BA1). In summary, this variant meets the criteria to be classified as Benign for FAP based on the ACMG/AMP criteria applied, as specified by the HCCP VCEP: BA1 and BP1 (VCEP specifications version 1; date of approval: 12/12/2022).
Met criteria codes
BA1
The highest population minor allele frequency in gnomAD v2.1.1 is 0.9598 (23897/24898 alleles) in the African/African American population, which is higher than the ClinGen APC VCEP threshold (>0.1%) for BA1, and therefore meets this criterion (BA1).
BP1
APC, in which the variant was identified, is defined by the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP as a gene for which primarily truncating variants are known to cause disease (BP1).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.